logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
A

Amit G. Pandya

university of massachusetts system

61H-index
286Paper Count
1.2WCitation Count
Published Papers 134
Publication Date
logo
Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies
errThe Lancet
IF88.5
err2026-08-13
err0
errOAAI
errThierry Passeron; Vimal H Prajapati; Raja K Sivamani; Khaled Ezzedine; Nanja van Geel; Iltefat Hamzavi; Amit G Pandya; David Rosmarin; Leihong Xiang; Tamio Suzuki; Seemal Desai; Mehdi Rashighi; Smitha Suravaram; Irina Fish; Xiaofei Hu; Xiaoqiang Wu; Minglu Wang; Yao Yu; Ahmed M Soliman; Heidi S Camp
errShare
errSave
Post Hoc Subgroup and Body Region Analyses of VASI Outcomes Among Patients with Vitiligo in a Phase 2 Povorcitinib Trial
errAdvances in Therapy
IF4
err2026-07-13
err0
errOAAI
errThierry Passeron; Amit G. Pandya; Khaled Ezzedine; Nanja van Geel; Lois Erskine; Leandro L. Santos; Zhenyi Xue; Andrew Blauvelt
errShare
errSave
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2026-01-01
err0
errOAAI
errHarris, John E.; Papp, Kim; Ezzedine, Khaled; Sebastian, Michael; Pandya, Amit G.; Seneschal, Julien; Amster, Mark; Shayesteh Alam, Maryam; Forman, Seth B.; Zdybski, Jacek; Nuara, Anthony; Kornacki, Deanna; Wei, Shaoceng; Passeron, Thierry; Rosmarin, David
errShare
errSave
Efficacy and Safety of Ruxolitinib Cream Combined With Narrow-Band UVB Phototherapy for Treatment of Vitiligo
errJournal of Investigative Dermatology
IF5.7
err2025-12-11
err0
PREAI
errAmit G. Pandya; Charles W. Lynde; Maryam Shayesteh Alam; Ira H. Thorla; Katherine Reed; Lawrence J. Green; Babak Soltanalizadeh; Diana Stefani-Hunyady; Deanna Kornacki; Mark S. Amster
errShare
errSave
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
errTherapeutic Advances in Chronic Disease
IF2.8
err2025-11-06
err0
errOAAI
errDavid Rosmarin; Thierry Passeron; Amit G. Pandya; Pearl Grimes; John E. Harris; Seemal R. Desai; Mark Lebwohl; Mireille Ruer‑Mulard; Julien Seneschal; Albert Wolkerstorfer; Deanna Kornacki; Kang Sun; Kathleen Butler; Khaled Ezzedine
errShare
errSave
Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo
errDermatology and Therapy
IF4.2
err2025-10-22
err0
errOAAI
errDavid Rosmarin; Amit G. Pandya; Thierry Passeron; Seth B. Forman; Jacek Zdybski; Mark Amster; Christina Feser; Kim A. Papp; Anthony Nuara; Deanna Kornacki; Shaoceng Wei; Haobo Ren; John E. Harris; Khaled Ezzedine
errShare
errSave
Assessment of vitiligo in clinical practice: a cross-sectional survey among experts
errJournal of Dermatological Treatment
IF3.9
err2025-10-10
err0
errOAAI
errJolien Duponselle; Marlide R. Jukema; Albert Wolkerstorfer; Khaled Ezzedine; Iltefat Hamzavi; Julien Seneschal; Viktoria Eleftheriadou; Amit G. Pandya; Amit Garg; Anand Ganesan; Boon Kee Goh; Davinder Parsad; Deepti Ghia; David Rosmarin; Giovanni Leone; Henry W. Lim; Hyun Jeong Ju; Jung Min Bae; John Ferguson; Laila Benzekri; Marwa Abdallah; Markus Böhm; Mauro Picardo; Mehdi Rashighi; M. Ramam; Michelle Rodrigues; Noufal Raboobee; Phyllis Spuls; Samia Esmat; Steven Tien Guan Thng; Thierry Passeron; Victor Huang; Reinhart Speeckaert; Nanja van Geel
errShare
errSave
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
errJournal of the American Academy of Dermatology
IF11.8
err2025-06-13
err0
errOAAI
errAmit G. Pandya; Khaled Ezzedine; Thierry Passeron; Nanja van Geel; Kurt Brown; Leandro L. Santos; Lois Erskine; Kofi Wagya; Andrew Blauvelt
errShare
errSave
Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2 , multicentre, randomised, double-blind, placebo-controlled, dose-ranging study (vol 73, 102655, 2024)
errECLINICALMEDICINE
IF10
err2025-04-01
err0
errOAAI
errPasseron, Thierry; Ezzedine, Khaled; Hamzavi, Lltefat; van Geel, Nanja; Schlosser, Bethanee J.; Wu, Xiaoqiang; Huang, Xiaohong; Soliman, Ahmed M.; Rosmarin, David; Harris, John E.; Camp, Heidi S.; Pandya, Amit G.
errShare
errSave
Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient population
errJournal of the American Academy of Dermatology
IF11.8
err2025-03-28
err0
errOAAI
errAmit G. Pandya; Bassel H. Mahmoud; Richard H. Huggins; Anand K. Ganesan; Nanette B. Silverberg; Girish Munavalli; Eduardo Weiss; Raheel Zubair; Karan Lal; J. Daniel Jensen; Maral Kibarian Skelsey; Navid Ezra; Robyn Siperstein; Claire Noell; Steven K. Grekin; Iltefat H. Hamzavi
errShare
errSave
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies
errDERMATOLOGY AND THERAPY
IF4.2
err2025-03-01
err0
errOAAI
errSeneschal, Julien; Wolkerstorfer, Albert; Desai, Seemal R.; Grimes, Pearl; Ezzedine, Khaled; Pandya, Amit G.; Kornacki, Deanna; Wei, Shaoceng; Passeron, Thierry; Rosmarin, David
errShare
errSave
Effective and durable repigmentation for stable vitiligo: A randomized within- subject controlled trial assessing treatment with autologous skin cell suspension transplantation
errJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
IF11.8
err2024-12-01
err0
errOAAI
errHamzavi, Iltefat H.; Ganes, Anand K.; Mahmoud, Bassel H.; Weiss, Eduardo; Ahmed, Ammar M.; Robinson, Deanne; Goldman, Mitchel P.; Munavalli, Girish; Kahn, Steven A.; Huang, Victor; Waibel, Jill; Desai, Alpesh; Elbuluk, Nada; Desai, Seemal; Pandya, Amit G.
errShare
errSave
A retrospective cross-sectional analysis of gender and racial/ethnic diversity trends in dermatology chairs
errJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
IF11.8
err2024-09-01
err0
errOAAI
errWilliams, Jazzmin C.; Valladares, Herbert Castillo; Waul, Michael A.; Mathes, Erin; Pandya, Amit G.; Amerson, Erin H.
errShare
errSave
Response to ritlecitinib with or without narrow band ultraviolet B (nbUVB) add-on therapy in patients with active non-segmental vitiligo (NSV)
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2024-08-08
err0
PREAI
errYamaguchi, Yuji; Peeva, Elena; Adiri, Roni; Ghosh, Pranab; Napatalung, Lynne; Hamzavi, Iltefat; Pandya, Amit G.; Shore, Ronald N.; Ezzedine, Khaled; Guttman-Yassky, Emma
errShare
errSave
Efficacy and safety of povorcitinib for extensive vitiligo: 52-week results from a double-blinded, placebo-controlled, dose-ranging phase 2b study
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2024-08-08
err0
PREAI
errPandya, Amit G.; Ezzedine, Khaled; Passeron, Thierry; van Geel, Nanja; Brown, Kurt; Santos, Leandro; Erskine, Lois; Wagya, Kofi; Blauvelt, Andrew
errShare
errSave
Efficacy of povorcitinib for the treatment of vitiligo by patient demographics and baseline clinical characteristics: week 52 subgroup analysis from a randomized, placebo-controlled, phase 2b clinical trial
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2024-08-08
err0
PREAI
errPandya, Amit G.; Passeron, Thierry; Blauvelt, Andrew; van Geel, Nanja; Brown, Kurt; Erskine, Lois; Xue, Zhenyi; Ezzedine, Khaled
errShare
errSave
Assessing Participants' Experiences with Vitiligo from Patient Interviews
errDERMATOLOGY AND THERAPY
IF4.2
err2024-08-05
err1
errOAAI
errPandya, Amit G.; Amoloja, Theresa; Bibeau, Kristen; DiBenedetti, Dana; Kosa, Katherine; Butler, Kathleen; Kornacki, Deanna; Ezzedine, Khaled
errShare
errSave
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks
errJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
IF8
err2024-07-16
err0
errOAAI
errPasseron, Thierry; Harris, John E.; Pandya, Amit G.; Seneschal, Julien; Grimes, Pearl; Kornacki, Deanna; Wang, Mingyue; Ezzedine, Khaled; Rosmarin, David
errShare
errSave
Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study
errECLINICALMEDICINE
IF10
err2024-07-01
err1
errOAAI
errPasseron, Thierry; Ezzedine, Khaled; Hamzavi, Iltefat; van Geel, Nanja; Schlosser, Bethanee J.; Wu, Xiaoqiang; Huang, Xiaohong; Soliman, Ahmed M.; Rosmarin, David; Harris, John E.; Camp, Heidi S.; Pandya, Amit G.
errShare
errSave
Economic Burden among Patients with Vitiligo in the United States: A Retrospective Database Claims Study
errJOURNAL OF INVESTIGATIVE DERMATOLOGY
IF5.7
err2024-03-01
err5
PREAI
errEzzedine, Khaled; Soliman, Ahmed M.; Li, Chao; Camp, Heidi S.; Pandya, Amit G.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
A
Andrew D. Luster
H-index: 130 · Papers: 446
L
Luis A. Díaz
H-index: 124 · Papers: 977
M
Mark Lebwohl
H-index: 120 · Papers: 1.4K
E
Emma Guttman‐Yassky
H-index: 115 · Papers: 761
A
Anantha P. Chandrakasan
H-index: 115 · Papers: 726
View more